# Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

> **NCT00224315** · PHASE4 · COMPLETED · sponsor: **Central Institute of Mental Health, Mannheim** · enrollment: 24 (—)

## Conditions studied

- Schizophrenia, Schizoaffective Disorder

## Interventions

- **DRUG:** ziprasidone
- **DRUG:** risperidone

## Key facts

- **NCT ID:** NCT00224315
- **Lead sponsor:** Central Institute of Mental Health, Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 24 (—)
- **Last updated:** 2008-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224315, "Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00224315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*